Between- and Within-Individual Sociodemographic and Psychological Determinants of PrEP Adherence Among Men Who have Sex with Men Prescribed a Daily PrEP Regimen in Wales

被引:0
作者
David Gillespie
Marijn de Bruin
Dyfrig A. Hughes
Richard Ma
Adam Williams
Fiona Wood
Zoë Couzens
Adam Jones
Kerenza Hood
机构
[1] Cardiff University,Centre for Trials Research, College of Biomedical & Life Sciences, School of Medicine
[2] Radboud University Medical Center,Centre for Health Economics and Medicines Evaluation
[3] Institute of Health Sciences,Division of Population Medicine and PRIME Centre Wales, College of Biomedical & Life Sciences, School of Medicine
[4] IQ Healthcare,Policy, Research and International Development
[5] Bangor University,undefined
[6] Imperial College London,undefined
[7] Cardiff University,undefined
[8] Public Health Wales NHS Trust,undefined
[9] Public Health Wales,undefined
来源
AIDS and Behavior | 2023年 / 27卷
关键词
HIV prevention; PrEP; Adherence; Determinants; MSM;
D O I
暂无
中图分类号
学科分类号
摘要
We investigated the determinants of daily PrEP use and coverage of condomless anal sex (CAS) by PrEP among men who have sex with men in Wales, UK. We measured PrEP use by electronic monitors and CAS by secure online surveys. We defined PrEP use based on daily medication cap openings and coverage as CAS episodes preceded by ≥ 3 days of PrEP use and followed by ≥ 2 days of PrEP use. We included 57 participants (5463 observations). An STI diagnosis was associated with lower PrEP use but also lower PrEP coverage. Older adults had higher PrEP use. A belief that other PrEP users took PrEP as prescribed was associated with lower PrEP coverage. An STI diagnosis is an important cue for an intervention, reflecting episodes of high-risk sexual behaviour and low PrEP coverage. Other results provide a basis for the development of an evidence-informed intervention for promoting coverage of PrEP.
引用
收藏
页码:1564 / 1572
页数:8
相关论文
共 74 条
  • [11] Charreau I(2022)PrEP use, sexual behaviour, and PrEP adherence among men who have sex with men living in Wales prior to and during the COVID-19 pandemic AIDS Behav 50 695-703
  • [12] Spire B(2013)Determinants of patient adherence: a review of systematic reviews Front Pharmacol 32 345-356
  • [13] McCormack S(1991)The theory of planned behavior Organ Behav Hum Decis Process 31 1165-1173
  • [14] Dunn DT(2017)Predicting adherence to combination antiretroviral therapy for HIV in Tanzania: a test of an extended theory of planned behaviour model Psychol Health 32 478-485
  • [15] Desai M(2012)Self-regulatory processes mediate the intention-behavior relation for adherence and exercise behaviors Health Psychol 22 518-529
  • [16] Haberer JE(1997)The electronic medication event monitor—lessons for pharmacotherapy Clin Pharmacokinet 72 578-584
  • [17] Van Damme L(2018)Utility of different adherence measures for PrEP: patterns and incremental value AIDS Behav 24 103-120
  • [18] Govinden R(2017)Single-dose pharmacokinetics and pharmacodynamics of oral tenofovir and emtricitabine in blood, saliva and rectal tissue: a sub-study of the ANRS IPERGAY trial J Antimicrob Chemother 68 697-705
  • [19] Mirembe FM(2001)Measuring stigma in people with HIV: psychometric assessment of the HIV stigma scale Res Nurs Health 4 e38-e61
  • [20] Halpern V(2015)The science of being a study participant: FEM-PrEP participants’ explanations for overreporting adherence to the study pills and for the whereabouts of unused pills J Acquir Immune Defic Syndr 33 1987-1996